Drug Repurposing for Emerging Infectious Diseases and Cancer 2023
DOI: 10.1007/978-981-19-5399-6_19
|View full text |Cite
|
Sign up to set email alerts
|

Drug Repurposing for COVID-19 Therapy: Pipeline, Current Status and Challenges

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 123 publications
0
1
0
Order By: Relevance
“…In this part of the work, new drug structures of fluvoxamine were designed by adding electron-donor/acceptor groups to the structure of fluvoxamine. [30][31] Then, in order to investigate serotonin absorption by new configurations of fluvoxamine, each of the designed structures was optimized in the gas phase and water environment using DFT theory at B3LYP-DFT/6-311 + G (d,p) theory level. First imaginary frequency and cohesive energy were investigated as basic factors in the stability of designed structures.…”
Section: Optimization Of Structures Of Serotonin and No 2 /Nh 2 -Fluv...mentioning
confidence: 99%
“…In this part of the work, new drug structures of fluvoxamine were designed by adding electron-donor/acceptor groups to the structure of fluvoxamine. [30][31] Then, in order to investigate serotonin absorption by new configurations of fluvoxamine, each of the designed structures was optimized in the gas phase and water environment using DFT theory at B3LYP-DFT/6-311 + G (d,p) theory level. First imaginary frequency and cohesive energy were investigated as basic factors in the stability of designed structures.…”
Section: Optimization Of Structures Of Serotonin and No 2 /Nh 2 -Fluv...mentioning
confidence: 99%